DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of ...
2h
StudyFinds on MSNBreakthrough blood test could transform ALS diagnosis, careFind out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
5h
News Medical on MSNStress granules as potential biomarkers for neurodegenerative diseasesStress granules (SGs) are transient organelles that form when cells experience stress, serving as critical hubs for RNA metabolism and cellular survival.
ALS, or amyotrophic lateral sclerosis, can sometimes be difficult to diagnose or to predict how quickly the disease is likely to progress. A new study helps determine which blood tests are best at ...
Her career with the #Dayton company followed her retirement as vice president at Procter & Gamble – where she executed a ...
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions ...
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
Tetramethylpyrazine nitrone is safe for ALS and may slow grip strength decline, especially in younger patients.
4d
HealthDay on MSNFour Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALSFour immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results